| Enhancement of CIITA transcriptional function by ubiquitin SF Greer, E Zika, B Conti, XS Zhu, JPY Ting Nature immunology 4 (11), 1074-1082, 2003 | 124 | 2003 |
| Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation E Zika, SF Greer, XS Zhu, JPY Ting Molecular and cellular biology 23 (9), 3091-3102, 2003 | 114 | 2003 |
| Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities F Becker, CG Van El, D Ibarreta, E Zika, S Hogarth, P Borry, ... European journal of human genetics 19 (1), S6-S44, 2011 | 109 | 2011 |
| Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes E Zika, JPY Ting Current opinion in immunology 17 (1), 58-64, 2005 | 109 | 2005 |
| A European survey on biobanks: trends and issues E Zika, D Paci, A Braun, S Rijkers-Defrasne, M Deschênes, I Fortier, ... Public health genomics 14 (2), 96-103, 2011 | 99 | 2011 |
| Biobanks in Europe: prospects for harmonisation and networking E Zika, D Paci, A Braun, S RijKers-Defrasne, M Deschênes, I Fortier, ... JRC Research Reports, 2010 | 92 | 2010 |
| Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-γ-inducible MHC-II gene expression E Zika, L Fauquier, L Vandel, JPY Ting Proceedings of the National Academy of Sciences 102 (45), 16321-16326, 2005 | 75 | 2005 |
| Bio-based Industries Joint Undertaking: The catalyst for sustainable bio-based economic growth in Europe P Mengal, M Wubbolts, E Zika, A Ruiz, D Brigitta, A Pieniadz, S Black New biotechnology 40, 31-39, 2018 | 74 | 2018 |
| Pharmacogenetics in Europe: barriers and opportunities D Gurwitz, E Zika, MM Hopkins, S Gaisser, D Ibarreta Public Health Genomics 12 (3), 134-141, 2009 | 68 | 2009 |
| Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases AH Wang, S Grégoire, E Zika, L Xiao, CS Li, H Li, KL Wright, JP Ting, ... Journal of Biological Chemistry 280 (32), 29117-29127, 2005 | 58 | 2005 |
| Consequences, opportunities and challenges of modern biotechnology for Europe E Zika, I Papatryfon, O Wolf, M Gómez-Barbero, AJ Stein, AK Bock Seville: Europe Comission, 2007 | 52 | 2007 |
| Provision and quality assurance of preimplantation genetic diagnosis in Europe A Corveleyn, MA Morris, E Dequeker, K Sermon, JL Davies, G Antinolo, ... European journal of human genetics 16 (3), 290-299, 2008 | 49 | 2008 |
| Sample, data use and protection in biobanking in Europe: legal issues E Zika, T Schulte In den Bäumen, J Kaye, A Brand, D Ibarreta Future Medicine Ltd 9 (6), 773-781, 2008 | 47 | 2008 |
| The histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivator JA Harton, E Zika, JPY Ting Journal of Biological Chemistry 276 (42), 38715-38720, 2001 | 36 | 2001 |
| The phantom menace of gene patents S Gaisser, MM Hopkins, K Liddell, E Zika, D Ibarreta Nature 458 (7237), 407-408, 2009 | 33 | 2009 |
| Steroid receptor coactivator 1 links the steroid and interferon γ response pathways E Tzortzakaki, C Spilianakis, E Zika, A Kretsovali, J Papamatheakis Molecular Endocrinology 17 (12), 2509-2518, 2003 | 28 | 2003 |
| Pharmacogenetics and Pharmacogenomics: State-of-the-art and Potential Socio-economic Impacts in the EU E Zika, D Gurwitz, D Ibarreta European Commission DG JRC/IPTS, EUR 22214, 2006 | 27 | 2006 |
| Preimplantation Genetic Diagnosis in Europe A Corveleyn, E Zika, M Morris, E Dequeker, JL Davies, K Sermon, ... European Communities 114, 57-75, 2007 | 17 | 2007 |
| The bio-based industries joint undertaking: a high impact initiative that is transforming the bio-based industries in Europe AR Sierra, E Zika, L Lange, PLR de Azúa, A Canalis, PM Esteban, ... New Biotechnology 60, 105-112, 2021 | 15 | 2021 |
| Consequences, opportunities and challenges of modern biotechnology for Europe I Papatryfon, E Zika, O Wolf, M Gómez-Barbero, AJ Stein, AK Bock Joint Research Centre–Institute for Prospective Technological Studies, 2008 | 11 | 2008 |
Francesc PalauHead of Dept. of Genetic and Molecular Medicine, Sant Joan de Déu Children's Hospital , BarcelonaVerified email at sjdhospitalbarcelona.org
